Filing Flows › Rapid Micro Biosystems (RPID) › Q1 2026 › vs Q1 2025
Rapid Micro Biosystems (RPID) Q1 2026 vs Q1 2025 (year over year)
Rapid Micro Biosystems's revenue rose $797K (+11%) from $7.2M in Q1 2025 to $8.0M in Q1 2026. The biggest changes: Product +$1.5M (+36%); Service −$680K (-22%).
Rapid Micro Biosystems, Q1 2026: revenue $8.0M (+11% year over year), operating margin -173.1%, net loss $14.3M, operating cash flow −$15.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Product | $5.6M | $4.1M | $1.5M | +36% |
| Service | $2.4M | $3.1M | −$680K | -22% |
| Revenue | $8.0M | $7.2M | $797K | +11% |
| Net loss | $14.3M | $11.3M | $3.0M | +27% |
| Costs & expenses | $22.3M | $18.9M | $3.4M | +18% |
| Operating costs | $21.9M | $18.9M | $3.0M | +16% |
| Interest & other, net | $415K | −$405K | $820K | — |
| Income tax | $8K | $7K | $1K | +14% |
| Cost of revenue | $7.6M | $6.8M | $830K | +12% |
| Research & development | $3.4M | $3.6M | −$265K | -7% |
| Sales & marketing | $3.4M | $2.8M | $671K | +24% |
| General & admin | $7.4M | $5.7M | $1.8M | +31% |
| Operating cash sources | $17.0M | $11.0M | $6.0M | +55% |
| Depreciation & amortization | $706K | $847K | −$141K | -17% |
| Share-based compensation | $1.2M | $1.0M | $181K | +17% |
| Cash used in operations | $15.1M | $9.1M | $6.0M | +66% |
| Net loss absorbed | $14.3M | $11.3M | $3.0M | +27% |
| Working capital & other | $2.7M | −$309K | $3.0M | — |
Questions
How much did Rapid Micro Biosystems's revenue grow year over year in Q1 2026?
Rapid Micro Biosystems's revenue rose $797K (+11%) from $7.2M in Q1 2025 to $8.0M in Q1 2026.
What drove Rapid Micro Biosystems's revenue change in Q1 2026?
Product +$1.5M (+36%); Service −$680K (-22%).